Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2024
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entitiesKatharina Möller, Tayyaba Gulzar, Maximilian Lennartz, et al.
Oncology Letters|December 15, 2018
High expression of class III β-tubulin in upper gastrointestinal cancer typesDoris Höflmayer, Eray Öztürk, Cornelia Schroeder, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
Pageof 19